Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

‘Not Yet But Shortly’: EU Remdesivir Filing

May 29 2020

• By Neena Brizmohun

Medication prepared for people affected by Covid-19, Remdesivir is a selective antiviral prophylactic against virus that is already in experimental use, conceptual image — Gilead is expected to file an EU marketing application for remdesivir soon • Source: Shutterstock

Related Content

Coronavirus Update: Setback With Hydroxychloroquine, Slowdown In UK ADR Reports, But Novel Drugs Begin Trials

May 26 2020

EMA’s Rasi: Approval Decision For Remdesivir May Come ‘Very Soon’

May 18 2020

Related Companies

Gilead Sciences, Inc.

Additional Topics

Europe Coronavirus COVID-19 Drug Review Approvals Market Access Regulation Infectious Diseases BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window